UY27870A1 - Nuevos derivados de quinuclidina-amida - Google Patents
Nuevos derivados de quinuclidina-amidaInfo
- Publication number
- UY27870A1 UY27870A1 UY27870A UY27870A UY27870A1 UY 27870 A1 UY27870 A1 UY 27870A1 UY 27870 A UY27870 A UY 27870A UY 27870 A UY27870 A UY 27870A UY 27870 A1 UY27870 A1 UY 27870A1
- Authority
- UY
- Uruguay
- Prior art keywords
- quinuclidina
- amida
- new derivatives
- formula
- therapy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Pulmonology (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Nuevos derivados de quinuclidina-amida que tienen la estructura química de fórmula general (I) y sales farmacéuticamente aceptables de los mismos, incluyendo las sales cuaternarias de fórmula (II) así como procedimientos para su preparación, las composiciones farmacéuticas que los contienen y su uso en terapia como antagonistas de receptores muscarínicos M3.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES200201539A ES2204295B1 (es) | 2002-07-02 | 2002-07-02 | Nuevos derivados de quinuclidina-amida. |
Publications (1)
Publication Number | Publication Date |
---|---|
UY27870A1 true UY27870A1 (es) | 2003-10-31 |
Family
ID=30011350
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY27870A UY27870A1 (es) | 2002-07-02 | 2003-06-27 | Nuevos derivados de quinuclidina-amida |
Country Status (24)
Country | Link |
---|---|
US (2) | US7488735B2 (es) |
EP (1) | EP1519933B1 (es) |
JP (1) | JP2005533826A (es) |
CN (1) | CN100404533C (es) |
AR (1) | AR040351A1 (es) |
AT (1) | ATE467631T1 (es) |
AU (1) | AU2003242757B2 (es) |
BR (1) | BR0312216A (es) |
CA (1) | CA2492535A1 (es) |
DE (1) | DE60332534D1 (es) |
EC (1) | ECSP045519A (es) |
ES (1) | ES2204295B1 (es) |
IL (1) | IL165923A (es) |
MX (1) | MXPA04012271A (es) |
MY (1) | MY130803A (es) |
NO (1) | NO20050164L (es) |
NZ (1) | NZ537341A (es) |
PE (1) | PE20040644A1 (es) |
RU (1) | RU2314306C2 (es) |
TW (1) | TW200402420A (es) |
UA (1) | UA80832C2 (es) |
UY (1) | UY27870A1 (es) |
WO (1) | WO2004005285A1 (es) |
ZA (1) | ZA200410404B (es) |
Families Citing this family (74)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2165768B1 (es) | 1999-07-14 | 2003-04-01 | Almirall Prodesfarma Sa | Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen. |
KR100869722B1 (ko) | 2000-12-22 | 2008-11-21 | 알미랄 에이쥐 | 퀴누클리딘 카르바메이트 유도체 및 m3 길항제로서 그의사용 |
ES2203327B1 (es) | 2002-06-21 | 2005-06-16 | Almirall Prodesfarma, S.A. | Nuevos carbamatos de quinuclidina y composiciones farmaceuticas que los contienen. |
TW200519106A (en) | 2003-05-02 | 2005-06-16 | Novartis Ag | Organic compounds |
GB0401334D0 (en) | 2004-01-21 | 2004-02-25 | Novartis Ag | Organic compounds |
ES2239546B1 (es) * | 2004-03-15 | 2006-12-01 | Almirall Prodesfarma, S.A. | Nuevos esteres de quinuclidina cuaternizados. |
PE20060259A1 (es) * | 2004-04-27 | 2006-03-25 | Glaxo Group Ltd | Compuestos de quinuclidina como antagonistas del receptor de acetilcolina muscarinico |
EP1747219A4 (en) * | 2004-05-13 | 2010-05-26 | Glaxo Group Ltd | Antagonists of muscarinic acetylcholine receptor |
GB0411056D0 (en) | 2004-05-18 | 2004-06-23 | Novartis Ag | Organic compounds |
ES2246170B1 (es) * | 2004-07-29 | 2007-04-01 | Almirall Prodesfarma, S.A. | Nuevo procedimiento para preparar derivados de carbamato de quinuclidinio. |
EP1790643B1 (en) * | 2004-09-15 | 2010-06-02 | Shuqiang Zhao | Quinuclidine compounds having quaternary ammonium group, it's preparation method and use as blocking agents of acetycholine |
GT200500281A (es) | 2004-10-22 | 2006-04-24 | Novartis Ag | Compuestos organicos. |
GB0426164D0 (en) | 2004-11-29 | 2004-12-29 | Novartis Ag | Organic compounds |
GB0507577D0 (en) | 2005-04-14 | 2005-05-18 | Novartis Ag | Organic compounds |
GB0510390D0 (en) | 2005-05-20 | 2005-06-29 | Novartis Ag | Organic compounds |
CA2625664C (en) | 2005-10-21 | 2016-01-05 | Novartis Ag | Human antibodies against il13 and therapeutic uses |
US9088384B2 (en) * | 2005-10-27 | 2015-07-21 | Qualcomm Incorporated | Pilot symbol transmission in wireless communication systems |
GB0601951D0 (en) | 2006-01-31 | 2006-03-15 | Novartis Ag | Organic compounds |
ATE549337T1 (de) | 2006-04-21 | 2012-03-15 | Novartis Ag | Purinderivate zur verwendung als adenosin-a2a- rezeptoragonisten |
ES2298049B1 (es) * | 2006-07-21 | 2009-10-20 | Laboratorios Almirall S.A. | Procedimiento para fabricar bromuro de 3(r)-(2-hidroxi-2,2-ditien-2-ilacetoxi)-1-(3-fenoxipropil)-1-azoniabiciclo (2.2.2) octano. |
WO2008037477A1 (en) | 2006-09-29 | 2008-04-03 | Novartis Ag | Pyrazolopyrimidines as p13k lipid kinase inhibitors |
PL2104535T3 (pl) | 2007-01-10 | 2011-05-31 | Irm Llc | Związki i kompozycje jako inhibitory proteazy aktywujące kanały |
JP5528817B2 (ja) * | 2007-02-23 | 2014-06-25 | セラヴァンス, インコーポレーテッド | ムスカリン受容体アンタゴニストとして有用な第四級アンモニウムジフェニルメチル化合物 |
ES2361595T3 (es) | 2007-05-07 | 2011-06-20 | Novartis Ag | Compuestos orgánicos. |
MX2010006421A (es) | 2007-12-10 | 2010-06-25 | Novartis Ag | Compuestos organicos. |
MX2010007604A (es) | 2008-01-11 | 2010-08-02 | Novartis Ag | Pirimidinas como inhibidores de cinasa. |
WO2009098455A1 (en) * | 2008-02-06 | 2009-08-13 | Astrazeneca Ab | 2- (9h-xanthen-9-yl) -oxazol derivatives as m3 muscarinic receptor antagonists for the treatment of asthma and chronic obstructive lung disease |
WO2009098453A1 (en) * | 2008-02-06 | 2009-08-13 | Astrazeneca Ab | Azonia bicycloalkanes as m3 muscarinic acetylcholin receptor antagonists |
EP2100599A1 (en) | 2008-03-13 | 2009-09-16 | Laboratorios Almirall, S.A. | Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease |
EP2100598A1 (en) | 2008-03-13 | 2009-09-16 | Laboratorios Almirall, S.A. | Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease |
US8268834B2 (en) | 2008-03-19 | 2012-09-18 | Novartis Ag | Pyrazine derivatives that inhibit phosphatidylinositol 3-kinase enzyme |
BRPI0915018A2 (pt) | 2008-06-10 | 2015-10-27 | Novartis Ag | compostos orgânicos |
GB0814729D0 (en) * | 2008-08-12 | 2008-09-17 | Argenta Discovery Ltd | New combination |
WO2010019099A1 (en) * | 2008-08-12 | 2010-02-18 | Astrazeneca Ab | 2-hydroxy-ethanesulfonate salt |
GB0814728D0 (en) * | 2008-08-12 | 2008-09-17 | Argenta Discovery Ltd | New combination |
WO2010088335A1 (en) | 2009-01-29 | 2010-08-05 | Novartis Ag | Substituted benzimidazoles for the treatment of astrocytomas |
US8389526B2 (en) | 2009-08-07 | 2013-03-05 | Novartis Ag | 3-heteroarylmethyl-imidazo[1,2-b]pyridazin-6-yl derivatives |
BR112012003262A8 (pt) | 2009-08-12 | 2016-05-17 | Novartis Ag | compostos de hidrazona heterocíclica e seus usos para tratar câncer e inflamação |
IN2012DN01961A (es) | 2009-08-17 | 2015-08-21 | Intellikine Llc | |
CA2771432A1 (en) | 2009-08-20 | 2011-02-24 | Novartis Ag | Heterocyclic oxime compounds |
EP2490687A1 (en) | 2009-10-22 | 2012-08-29 | Vertex Pharmaceuticals Incorporated | Compositions for treatment of cystic fibrosis and other chronic diseases |
US8247436B2 (en) | 2010-03-19 | 2012-08-21 | Novartis Ag | Pyridine and pyrazine derivative for the treatment of CF |
UY33597A (es) | 2010-09-09 | 2012-04-30 | Irm Llc | Compuestos y composiciones como inhibidores de la trk |
WO2012034095A1 (en) | 2010-09-09 | 2012-03-15 | Irm Llc | Compounds and compositions as trk inhibitors |
US8372845B2 (en) | 2010-09-17 | 2013-02-12 | Novartis Ag | Pyrazine derivatives as enac blockers |
WO2012107500A1 (en) | 2011-02-10 | 2012-08-16 | Novartis Ag | [1, 2, 4] triazolo [4, 3 -b] pyridazine compounds as inhibitors of the c-met tyrosine kinase |
EP2678016B1 (en) | 2011-02-23 | 2016-08-10 | Intellikine, LLC | Heterocyclic compounds and uses thereof |
BR112013021638A2 (pt) | 2011-02-25 | 2016-08-02 | Irm Llc | "compostos inibidores de trk, seu uso e composições que os compreendem" |
EP2510928A1 (en) | 2011-04-15 | 2012-10-17 | Almirall, S.A. | Aclidinium for use in improving the quality of sleep in respiratory patients |
KR20140019409A (ko) * | 2011-04-29 | 2014-02-14 | 키에시 파르마슈티시 엣스. 피. 에이. | 알칼로이드 에스텔 및 카바메이트 유도체와 그들의 의약조성물 |
US8883819B2 (en) | 2011-09-01 | 2014-11-11 | Irm Llc | Bicyclic heterocycle derivatives for the treatment of pulmonary arterial hypertension |
MX339302B (es) | 2011-09-15 | 2016-05-19 | Novartis Ag | 3-(quinolin-6-il-tio)-[1,2,4]-triazolo-[4,3-a]-piridinas 6-sustituidas como cinasas de tirosina. |
WO2013038378A1 (en) | 2011-09-16 | 2013-03-21 | Novartis Ag | Pyridine amide derivatives |
WO2013038386A1 (en) | 2011-09-16 | 2013-03-21 | Novartis Ag | Heterocyclic compounds for the treatment of cystic fibrosis |
JP6165733B2 (ja) | 2011-09-16 | 2017-07-19 | ノバルティス アーゲー | N−置換ヘテロシクリルカルボキサミド類 |
WO2013038381A1 (en) | 2011-09-16 | 2013-03-21 | Novartis Ag | Pyridine/pyrazine amide derivatives |
WO2013038373A1 (en) | 2011-09-16 | 2013-03-21 | Novartis Ag | Pyridine amide derivatives |
WO2013078440A2 (en) | 2011-11-23 | 2013-05-30 | Intellikine, Llc | Enhanced treatment regimens using mtor inhibitors |
US8809340B2 (en) | 2012-03-19 | 2014-08-19 | Novartis Ag | Crystalline form |
ES2894830T3 (es) | 2012-04-03 | 2022-02-16 | Novartis Ag | Productos combinados con inhibidores de tirosina·cinasa y su uso |
US9073921B2 (en) | 2013-03-01 | 2015-07-07 | Novartis Ag | Salt forms of bicyclic heterocyclic derivatives |
WO2014151147A1 (en) | 2013-03-15 | 2014-09-25 | Intellikine, Llc | Combination of kinase inhibitors and uses thereof |
KR101823451B1 (ko) * | 2013-07-13 | 2018-01-30 | 베이징 에프에스웰컴 테크놀로지 디벨롭먼트 컴퍼니 리미티드 | 퀴논계 화합물, 이의 광학 이성질체 및 이의 제조 방법과 의약 용도 |
TW201605450A (zh) | 2013-12-03 | 2016-02-16 | 諾華公司 | Mdm2抑制劑與BRAF抑制劑之組合及其用途 |
MX2016013981A (es) | 2014-04-24 | 2016-11-15 | Novartis Ag | Derivados de amino-piridina como inhibidores de fosfatidil-inositol-3-cinasa. |
CA2945212A1 (en) | 2014-04-24 | 2015-10-29 | Novartis Ag | Amino pyrazine derivatives as phosphatidylinositol 3-kinase inhibitors |
JP6404944B2 (ja) | 2014-04-24 | 2018-10-17 | ノバルティス アーゲー | ホスファチジルイノシトール3−キナーゼ阻害薬としてのピラジン誘導体 |
RU2016152499A (ru) * | 2014-05-30 | 2018-07-04 | Драг Дискавери Ресеч Сентэ | Новые соединения в качестве противотуберкулезных препаратов |
WO2016011658A1 (en) | 2014-07-25 | 2016-01-28 | Novartis Ag | Combination therapy |
US10195208B2 (en) | 2014-07-31 | 2019-02-05 | Novartis Ag | Combination therapy |
KR20220019015A (ko) | 2019-06-10 | 2022-02-15 | 노파르티스 아게 | Cf, copd, 및 기관지확장증 치료를 위한 피리딘 및 피라진 유도체 |
WO2021038426A1 (en) | 2019-08-28 | 2021-03-04 | Novartis Ag | Substituted 1,3-phenyl heteroaryl derivatives and their use in the treatment of disease |
CN110759904B (zh) * | 2019-10-21 | 2023-03-14 | 河南科技大学 | 9r-酰氧基奎宁类衍生物及其制备方法、奎宁或其衍生物的应用、植物源杀虫剂 |
TW202140550A (zh) | 2020-01-29 | 2021-11-01 | 瑞士商諾華公司 | 使用抗tslp抗體治療炎性或阻塞性氣道疾病之方法 |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2762796A (en) * | 1956-09-11 | Iminodibenzyl derivative | ||
GB1219606A (en) * | 1968-07-15 | 1971-01-20 | Rech S Et D Applic Scient Soge | Quinuclidinol derivatives and preparation thereof |
GB1246606A (en) | 1969-04-28 | 1971-09-15 | Starogardzkie Zakl Farma | Dibenzo-azepine derivatives |
IL72788A (en) | 1984-08-28 | 1989-07-31 | Israel State | Bis quaternary oxy-bis methylene(or trimethylene)bis-n-quinuclidines,pyridines and piperidines,their preparation and antidotes against organophosphorus and carbamate poisoning containing them |
GB2225574B (en) | 1987-12-24 | 1991-04-24 | Wyeth John & Brother Ltd | Heterocyclic compounds |
GB8825505D0 (en) * | 1988-11-01 | 1988-12-07 | Pfizer Ltd | Therapeutic agents |
GB8923590D0 (en) * | 1989-10-19 | 1989-12-06 | Pfizer Ltd | Antimuscarinic bronchodilators |
GB9201751D0 (en) | 1992-01-28 | 1992-03-11 | Smithkline Beecham Plc | Compounds |
GB9202443D0 (en) * | 1992-02-05 | 1992-03-18 | Fujisawa Pharmaceutical Co | A novel substituted-acetamide compound and a process for the preparation thereof |
WO1995006635A1 (fr) * | 1993-09-02 | 1995-03-09 | Yamanouchi Pharmaceutical Co., Ltd. | Derive de carbamate et medicament le contenant |
CA2182568A1 (en) | 1994-02-10 | 1995-08-17 | Makoto Takeuchi | Novel carbamate derivative and medicinal composition containing the same |
NO2005012I1 (no) | 1994-12-28 | 2005-06-06 | Debio Rech Pharma Sa | Triptorelin og farmasoytisk akseptable salter derav |
AU7145996A (en) * | 1995-10-13 | 1997-04-30 | Banyu Pharmaceutical Co., Ltd. | Substituted heteroaromatic derivatives |
AUPN862996A0 (en) | 1996-03-13 | 1996-04-04 | Fujisawa Pharmaceutical Co., Ltd. | A novel substituted-acetamide compound |
PE92198A1 (es) * | 1996-08-01 | 1999-01-09 | Banyu Pharma Co Ltd | Derivados de 1,4-piperidina disustituida que contienen fluor |
ES2165768B1 (es) * | 1999-07-14 | 2003-04-01 | Almirall Prodesfarma Sa | Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen. |
HU229306B1 (en) | 2000-06-27 | 2013-10-28 | L V A T Lab Sa | Carbamates derived from arylalkylamines |
KR100869722B1 (ko) * | 2000-12-22 | 2008-11-21 | 알미랄 에이쥐 | 퀴누클리딘 카르바메이트 유도체 및 m3 길항제로서 그의사용 |
ATE334128T1 (de) * | 2000-12-28 | 2006-08-15 | Almirall Prodesfarma Ag | Neue chinuclidinderivate und medizinische zusammensetzungen, die diese verbindungen enthalten |
EP1461336B1 (en) | 2001-12-20 | 2013-05-22 | CHIESI FARMACEUTICI S.p.A. | 1-alkyl-1-azoniabicyclo (2.2.2) octane carbamate derivatives and their use as muscarinic receptor antagonists |
ES2203327B1 (es) | 2002-06-21 | 2005-06-16 | Almirall Prodesfarma, S.A. | Nuevos carbamatos de quinuclidina y composiciones farmaceuticas que los contienen. |
KR20050052500A (ko) * | 2002-09-19 | 2005-06-02 | 쉐링 코포레이션 | 사이클린 의존성 키나제 억제제로서의 이미다조피리딘 |
-
2002
- 2002-07-02 ES ES200201539A patent/ES2204295B1/es not_active Expired - Fee Related
-
2003
- 2003-06-25 AU AU2003242757A patent/AU2003242757B2/en not_active Ceased
- 2003-06-25 JP JP2004518575A patent/JP2005533826A/ja active Pending
- 2003-06-25 RU RU2005102585/04A patent/RU2314306C2/ru not_active IP Right Cessation
- 2003-06-25 MX MXPA04012271A patent/MXPA04012271A/es active IP Right Grant
- 2003-06-25 DE DE60332534T patent/DE60332534D1/de not_active Expired - Fee Related
- 2003-06-25 CA CA002492535A patent/CA2492535A1/en not_active Abandoned
- 2003-06-25 WO PCT/EP2003/006708 patent/WO2004005285A1/en active Application Filing
- 2003-06-25 CN CNB03820648XA patent/CN100404533C/zh not_active Expired - Fee Related
- 2003-06-25 US US10/518,714 patent/US7488735B2/en not_active Expired - Fee Related
- 2003-06-25 AT AT03762514T patent/ATE467631T1/de not_active IP Right Cessation
- 2003-06-25 NZ NZ537341A patent/NZ537341A/xx unknown
- 2003-06-25 EP EP03762514A patent/EP1519933B1/en not_active Expired - Lifetime
- 2003-06-25 UA UAA200500839A patent/UA80832C2/uk unknown
- 2003-06-25 BR BR0312216-6A patent/BR0312216A/pt not_active IP Right Cessation
- 2003-06-27 UY UY27870A patent/UY27870A1/es not_active Application Discontinuation
- 2003-06-30 AR ARP030102368A patent/AR040351A1/es unknown
- 2003-06-30 MY MYPI20032447A patent/MY130803A/en unknown
- 2003-06-30 PE PE2003000662A patent/PE20040644A1/es not_active Application Discontinuation
- 2003-07-02 TW TW092118081A patent/TW200402420A/zh unknown
-
2004
- 2004-12-22 IL IL165923A patent/IL165923A/en not_active IP Right Cessation
- 2004-12-23 ZA ZA200410404A patent/ZA200410404B/xx unknown
- 2004-12-29 EC EC2004005519A patent/ECSP045519A/es unknown
-
2005
- 2005-01-12 NO NO20050164A patent/NO20050164L/no not_active Application Discontinuation
-
2008
- 2008-01-08 US US11/970,698 patent/US7718670B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
MXPA04012271A (es) | 2005-04-08 |
ZA200410404B (en) | 2005-09-05 |
RU2005102585A (ru) | 2005-10-10 |
EP1519933A1 (en) | 2005-04-06 |
US20080234316A1 (en) | 2008-09-25 |
IL165923A (en) | 2010-06-30 |
CN1678610A (zh) | 2005-10-05 |
BR0312216A (pt) | 2005-04-12 |
ECSP045519A (es) | 2005-03-10 |
AU2003242757A1 (en) | 2004-01-23 |
US20060167042A1 (en) | 2006-07-27 |
US7718670B2 (en) | 2010-05-18 |
CN100404533C (zh) | 2008-07-23 |
AU2003242757B2 (en) | 2009-01-08 |
IL165923A0 (en) | 2006-01-15 |
JP2005533826A (ja) | 2005-11-10 |
DE60332534D1 (de) | 2010-06-24 |
ATE467631T1 (de) | 2010-05-15 |
EP1519933B1 (en) | 2010-05-12 |
PE20040644A1 (es) | 2004-09-18 |
RU2314306C2 (ru) | 2008-01-10 |
WO2004005285A1 (en) | 2004-01-15 |
AR040351A1 (es) | 2005-03-30 |
ES2204295B1 (es) | 2005-08-01 |
ES2204295A1 (es) | 2004-04-16 |
NZ537341A (en) | 2006-04-28 |
MY130803A (en) | 2007-07-31 |
NO20050164L (no) | 2005-04-04 |
US7488735B2 (en) | 2009-02-10 |
UA80832C2 (en) | 2007-11-12 |
TW200402420A (en) | 2004-02-16 |
CA2492535A1 (en) | 2004-01-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UY27870A1 (es) | Nuevos derivados de quinuclidina-amida | |
UY27760A1 (es) | Nuevos derivados de pirrolidinio. | |
UY27850A1 (es) | Nuevos carbamatos de quinuclidina y composiciones farmacéuticas que los contienen | |
ES2195785B1 (es) | Nuevos derivados de piridazin-3(2h)-ona. | |
UY29781A1 (es) | Compuestos diazaspiro sustituidos, sales farmacéuticamente aceptables, composiciones farmacéuticas que contienen los compuestos o sales, métodos de preparación y usos | |
ECSP034774A (es) | Pirazolopirimmidinas como agentes terapeuticos | |
ECSP034773A (es) | Pirazolopirimmidinas como agentes terapeuticos | |
UY29087A1 (es) | Derivados de adamantilo, composiciones farmaceuticas que los contienen, procesos para su preparacion y uso terapeutico | |
UY28510A1 (es) | Compuestos quimicos | |
PA8657501A1 (es) | Derivados de piperida y su uso como agentes antiinflamatorios | |
ECSP056194A (es) | Derivados de pirazolo-quinazolina, procedimiento para su preparacion y su uso como inhibidores de quinasa | |
UY28342A1 (es) | Nuevos compuestos | |
UY27740A1 (es) | Nuevos compuestos | |
ECSP10010197A (es) | Derivados de piridina y pirazina útiles en el tratamiento de trastornos de proliferación celular | |
UY29875A1 (es) | Compuestos quimicos | |
UY30327A1 (es) | Nuevos compuestos ii | |
PA8575401A1 (es) | Derivados de heteroarilamida benzocondensada de tienopiridinas utiles como agentes terapeuticos, composiciones farmaceuticas que incluyen a los mismos y metrodos para su uso | |
SV2005001979A (es) | "pirido[2,3-d]pirimidina-2,4-diaminas como inhibidores de pde 2 " ref. pc25123a | |
UY32203A (es) | Amino pirimidinas y su uso en terapia | |
UY28026A1 (es) | 4-piperazinilbencenosulfonilindoles y usos de los mismos. | |
BRPI0517792A (pt) | macrolonas - quinolonas amino-substituìdas | |
SE0401345D0 (sv) | Therapeutic compounds: Pyridine as scaffold | |
SE0402762D0 (sv) | Indazole sulphonamide derivatives | |
UY28536A1 (es) | Derivados de bencimidazol, composiciones que los contienen, preparacion y usos de los mismos. | |
UY29892A1 (es) | Nuevos derivados de cromano, composiciones farmaceuticas conteniendolos, procesos de preparacion y aplicaciones |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
109 | Application deemed to be withdrawn |
Effective date: 20150522 |